on pe modelling this issue is avoid however if you ROE over year and DCF it looks a good bet.... plus management looks clean and hard working i am going read red herring and also do more modelling before make my decision on this
BID/OFFER OPENS ON Tuesday, February 02, 2016 BID/OFFER CLOSES ON Thursday, February 04, 2016 FINALISATION OF BASIS OF ALLOTMENT On or before February 09, 2016
INITIATION OF REFUNDS FOR ANCHOR On or before February 10, 2016 INVESTORS/UNBLOCKING OF FUNDS
CREDIT OF EQUITY SHARES TO DEPOSITORY ACCOUNTS On or before February 11, 2016
COMMENCEMENT OF TRADING On or before February 12, 2016
Ikya Global was valued at c.368 Cr in 2013. It''s revenues today are at the same level as TeamLease but its net profit margin is 3x that of TL. Compare TL''s current likely capitalization of c.1,350 Cr.
Ikya is eying for a 3,000 Cr + valuation in just 3 years. More than 8x increase in 3 years. We might see Ikya''s IPO sometime around mid-2016 depending perhaps on what happens to TL''s IPO.
25.1. Septa| Link| Bookmark|
January 27, 2016 11:35:34 AM
(4000+ Posts, 4600+ Likes)
nice
24. Eagleye| Link| Bookmark|
January 27, 2016 10:55:22 AM
IPO Guru (6600+ Posts, 22000+ Likes)
Thomas Cook acquired HR company Ikya Human Solutions in 2013 70% stake at 256 cr this company was bigger then team lease at that time and is bigger according to Thomas cook BS
if that the case if it sure short why beware apply and sell just confused anyway i am not applying how tempting bcoz i will not buy it on secondary market at 850 forget 1100
Beware is to make wise decision so that my post should not lure investors to apply. Meanwhile its confirmed that big players will play with this stock.
and many did not have any GMP but gave handsome return PCF infra mansaspand and my favourite shree pushkar
18.8. Ou Ai| Link| Bookmark|
January 27, 2016 1:18:34 PM
Top Contributor (300+ Posts, 300+ Likes)
Most times in fact. Grey market demand appears only during continuous bull market. It vanishes if there couple of issue tanks down below issue price trapping innocent or new bees or when the market is in successive downtrend as it is today. I am reading this board over last 10 years. With every bear market over 80% of the boarders here vanish and a new of boarders on board till the next route. Those who remain are the ones who don''t get carried away by ups & downs, what is written in RHP , PE calculations, but have the patience to wait and make money.
Companies that were planning initial public offerings (IPOs), after being enthused by the recovery in he local equity markets last year, are being forced to wait becaof the uncertainty caused by recent volatility.
L&T Infotech, the IT unit of engineer ng and construction giant L&T, had been planning to raise up to Rs 2,000 crore in what would have been one of the largest IPOs this year. The sale is now unlikely to take place this fiscal, bankers said.
Infibeam, the first ecommerce company planning to list its shares in the domestic market, may also postpone `450-crore IPO. Others such as Paits.rag Milk Foods, Amar Ujala Publications and Catholic Syrian Bank, which have received approvals from the Sebi for share sales, will wait for a more opportune time, bankers said.
"A company has to choose between timing and pricing of an issue -it cannot get both. Companies which have an urgency to give some investors an exit, raise funds or lower debt could still go ahead. But the volatility in the market now means that many may choose to wait," said KVS Manian, president, corporate and investment banking, Kotak Mahindra Bank. IPO filings with September quarter audited results are valid for 135 days, which means they will lapse by mid-February. After that, the companies will need to update the numbers.
one way staripo is right when market correct it real corrects value falls big time no one is spared anyway indian stock market is at higher PE multiple compare to all EM and developed market.... if it was not for the present interest in DIIs market would have correct more......even after correct nifty PE is in high teens
NO NO NO PLZ STAY AWAY FROM SUCH LOOTERS COMING WITH IPO AT SUCH HIGH VALUATION. DONT TAKE RISK IN SUCH STOCKS. ALL THE PREMIUM OF THI STOCK WILL BE VANISHED SOON EVEN AT 20 P/E IT DOES NOT DESERVE TO GET SUBSCRIBED AND ITS COMING WITH 70P/E
SYTAY AWAY LOT OF GOOD OPPURNUITES COMING IN SECONDARY MARKET AND TEMPTING VALUATON
VALUATION IS KEY BUY RIGHT AND SIT TIGHT. NO ONE SHOULD BE INTERESTED TO APPLY IN THIS IPO IN SUCH MARKET CONDITION
STAY AWAY PLEASE.
12. Eagleye| Link| Bookmark|
January 26, 2016 2:57:50 PM
IPO Guru (6600+ Posts, 22000+ Likes)
Seniors Members please, I need your help ... I am sooo confused about Teamlease ... I just cannot fathom how to value this stock ... it is a full-tooo bouncer ... and I am unable to play this stock valuation game ... How do I tame this animal?
Issue Price 850 + GMP 235 = almost 1100/- ... OMG !!! ... I am unable to comprehend the dynamics going on here ... NEED YOUR HELP !!!
if you do understand stay away one very wiseman once said to me and i am saying the same to you..... one thing is clear premium is very high and GMP is also very high not much floating stock. As arjun said this will create an artificial demand and let at such high premium if some one is buying at 235 he is expecting to make at least 235 given the premium play we have seen lately with other issue so the punter is expecting it to list at 1335/- just based on NL dr lal and alkem GMP and listing price....
I am not going to apply and avoid as my game play is different....
Dont compare such with global peers As in India company like Indigo trade at 1300 at 50k Cr. Capitalization
Indigo was operators play and now company dragged to 870 value even knowing that Crude at 10 years low.
Teamlease is valued high.
Its valued at 8x to Mv/Ev which is not that high. Now valuation of Service sector company generally done by DCF Technique
Where cash flows are discounted at Present value system
Which find DCF on Google you will understand the process. I will repeat that Teamlease is valued ar 1440 Cr. At cash flow of 30Cr. Discounted @15% As per me slightly on a higher side.
But remember they were coming with 500 cr. Ipo which now is reduced to 423Cr. Just becaof sentiment. If ita operators driven you cant imagine valuation but post listing should cool down around 675-725. But till its in operators hand they can drag this till 1250 in no time. Remember operotors can play both side
well said and put forward ur argument.... i am not against DCF valuation many biocon companies had very steep valuation based on DCF in USA but when projected cash flow did not happen it crashed... same was with tech boom... short term or listing gain is possible but will u buy this fundamental my answer is no..... QIB subscription is important and 12x is good guide line for those looking for listing gain.
total income or cash flow is high bcoz billing is done team lease end same thing the out flow is big bcoz they have to pay all the temp employees.. .so i will not going to take mv/revenue in real terms.....the real income is the difference in what the pay and what the get
I''m not a senior member, but still I am daring a response...
My DCF Valuation: Assumptions: (1) They grew 30% in FY15, 20% in FY16 (on annualised basis). Post issue in FY17 and FY 18, I have taken 25% sales growth. I''ve removed non-op income from topline as discussed earlier. For next 2 yrs, sales growth 20%. For next 2 yrs, sales growth 15%. For next 2 yrs, sales growth 10%. Then 5% long term growth in perpetuity ( India''s LT GDP/ Inflation rate). (2) EBITDA margin: 10 bps increase in first 2 yrs as they are expected to enter into higher value added segments. For remaining yrs only 5 bps improvement. (3)CapEx and WC changes are not an issue for this business. Hence regular projections in line with historical trends. (4) Since I have removed Non-Operating income from sales which includes a ''recurring'' item of 74 Million (FD intetest), I have added 70 M cash inflow for all the yrs. Rest of the items in Non-Operating income are ''non- recurring'' and hence not projected for. (5) Cost of debt: 2% since all their loans are demand loans against FDs with interest 2% over the underlying FD intetest rate. (6) Cost of capital or IRR: This is chosen by the investors. For ex: If I choose high IRR then WACC (discount rate) for the projected cash flows will be high and Valuation will be low.
With these assumptions, I get 10.7% IRR for share price of 818 ( Mid point of offer range) which implies 3% premium over Risk Free Rate of 7.7% for all the risks ur taking with this company.
This means that if the company is on track with the sales and margin projections, you will keep getting 10.7% return on ur investment. Now if u think u need at least 12% return for such risks then this issue is overpriced as per your Valuation.
If ur bullish on the company and the think that it will grow at much higher rate say 30% instead of 15%-25% that I have assumed then ur Valuation would be higher than mine & ur IRR will be higher than mine say 12% instead of 10.7%.
QIBs do exactly this & take a call whether company''s growth prospects are providing them the IRR they r looking for...
As you would have understood by now that everybody has his own assumptions about sales, margin etc and thus has different valuations & implied IRR. The question is who gets it right? Who is fairest of them all? 10.7% return provided company achieves as much as I am projecting may be good enough for a retail investor but a MF manager may lose his job at such returns.
So, pick ur poison (assumptions)! I have chosen to be guided by my own stupidity.
Gravitas great job but all DCF have a very important factor margin of safety going rate is 30% just based on ur assumption 818 at 30% issue price should be 573 on higher side so merchant banker have assumed bigger growth factors to get to this 850 rupee per share after 30% margin of safety
BTW what the initial cashflow . i took present NOPA and the number i got was Rs 952.97 and 30% safety Rs 667.08 so IMO 670 or below should be offer price
That''s exactly the problem. I reckon my assumptions as reasonable but I do not get any credible margin of safety. In ur own words, they are not leaving anything on the table. Valuations are highly stretched for both PCL as well as TL and they are reflecting in P/E ratios as well.
I wonder how bullish can QIBs be. Perhaps there are things that they know but we don''t.....
I do not have access to my excel spreads right now so don''t know the CF for FY16 but CF each year is = EBITDA + D&A- Tax- CapEx +/- WC changes + 70 millions non-op cash (FD interest). Each year CF is then discounted @ WACC.
But, let''s not think that QIBs or NIIs get it right all the time... Monte Carlo, CCD, Adlabs etc are glaring examples where they have been caught on the wrong foot. Much to the embarrassment of the Underwriters, QIBs suffered huge losses in these IPOs just like anybody else.
Even successful ones like NH, DrLal etc are not necessarily correctly priced, they could be being saved by huge ''sentiments'' associated with the company/promoters (Dr Shetty/ Dr Lal?). Let their first annual report post IPO come out, let the dust settle, and there could be a significant correction.